Health in Honduras 1,088 indicators covering health for Honduras. IndicatorLatest Year10-yr change Rank Life satisfaction vs life expectancy 72.88 2023 up 3.0% 135th Estimate of current cigarette smoking prevalence 10.0% 2030 down 10.7% 98th Estimate of current cigarette smoking prevalence (%) 10.1% 2030 down 10.6% 97th Tb patients tested positive for hiv 116 2021 down 55.6% 83rd Number of children aged 6-59 months with anaemia 265.16 2019 down 25.3% 85th Prevalence of anaemia in children aged 6-59 months 26.2% 2019 down 23.2% 99th Number of deaths attributed to non-communicable diseases, by type of 6,098 2019 up 45.6% 110th Hepatitis B surface antigen (HBsAg) prevalence 0.0% 2024 — 132nd Mean hemoglobin level of children aged 6-59 months 117 2019 up 2.6% 89th Estimated number of MDR/RR-TB incident cases 87 2024 down 8.4% 97th Mortality caused by road traffic injury 16.1 per 100,000 population 2019 down 1.2% 85th Mortality caused by road traffic injury, female 11.3 per 100,000 female population 2019 down 4.2% 58th Mortality caused by road traffic injury, male 21 per 100,000 male population 2019 up 0.5% 104th Countries with birth registration data that are at least 90 percent 0 2024 — 138th Ipv vaccine coverage 74 2024 up 722.2% 164th Tb patients living with hiv receiving art 86 2021 down 54.3% 82nd HIV-positive TB patients on ART (antiretroviral therapy) 87.0% 2024 up 6.1% 102nd Hospital beds 5.29 2023 down 17.0% 142nd Treatment success rate for patients treated for MDR-TB 57.0% 2022 up 42.5% 129th New leprosy case detection rate per 1 000 000 population 0 2024 down 100.0% 124th Treatment success rate: HIV-positive TB cases 63 2023 down 12.5% 113th Prevalence of wasting, weight for height 1.9% 2019 up 35.7% 80th Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 87.0% 2025 — 94th International Health Regulations core capacity scores, SPAR version 30 2025 — 138th Prevalence of underweight, weight for age 7.1% 2019 down 18.4% 57th Leprosy registered prevalence rate per 1 000 000 population 0 2024 down 100.0% 121st Leprosy - Number of new leprosy cases among children 0 2024 down 100.0% 69th Leprosy - Number of cases registered for treatment 0 2024 down 100.0% 121st New leprosy child case detection rate (less than 15 years of age) per 0 2024 down 100.0% 69th Children (0-14) living with HIV 630 2024 down 60.6% 62nd Ipv1 number unvaccinated 59,506 2023 down 69.8% 49th Children living with hiv 630 2024 down 60.6% 62nd Contraceptive prevalence, any method 69.4% 2019 up 6.4% 23rd Children (ages 0-14) newly infected with HIV 100 2024 down 50.0% 51st Number of reported cases of poliomyelitis by wild poliovirus 0 2023 — 3rd Age-standardized prevalence of current tobacco use among persons aged 12.1% 2024 down 11.0% 108th Number of children newly infected with hiv 100 2024 down 50.0% 51st Share of children under fifteen years old with hiv 69.48 2024 down 35.2% 55th Number of female leprosy new cases 0 2024 down 100.0% 102nd Estimated number of malaria deaths 0 2024 down 100.0% 66th Estimated number of malaria cases 2,292 2024 down 50.1% 66th National smoking ban: NUMBER OF PLACES SMOKE-FREE 8 2022 unchanged 1st Contraceptive prevalence, any modern method 66.5% 2019 up 17.9% 16th Number of prevalent tuberculosis cases 3,900 2014 down 51.2% 104th Estimated malaria incidence 0.2337 2024 down 58.2% 68th Estimated malaria mortality rate 0 2024 down 100.0% 66th Number of new G2D leprosy cases 0 2024 — 86th Leprosy - New leprosy cases with G2D rate per 1 000 000 population 0 2024 — 86th Inflation-adjusted prices for most sold brand of cigarettes: Prices 6.35 2022 up 54.9% 91st Taxes as a % of price: total tax 38.3% 2022 up 12.5% 136th Taxes as a % of price: value added tax 15.2% 2022 up 16.9% 50th Taxes as a % of price: ad valorem excise 0.0% 2022 — 106th Taxes as a % of price: specific excise 15.4% 2022 down 26.6% 111th Taxes as a % of price: import duties 7.6% 2022 — 16th Taxes as a % of price: other taxes 0.0% 2022 — 56th Inflation-adjusted prices for most sold brand of cigarettes: Price in 70 2022 up 33.0% 80th Estimated number of children needing antiretroviral therapy based on 620 2025 down 61.2% 61st Prevalence of severe wasting, weight for height 0.5% 2019 up 66.7% 67th Physical activity policies for activie societies 20 2023 up 100.0% 2nd Physical activity policies focused on active systems 20 2023 unchanged 5th ← Previous Page 15 of 19 Next →